CSPC Innovation Pharmaceutical Stock Forecast for 2023 - 2025 - 2030

Updated on 05/01/2024

Stock Rating
0
Price Target
38.46
Consensus
Outperform
Upside
12.23%
Analysts
0
Stock Rating
0
Upside
12.23%
Analysts
0
Price Target
38.46

CSPC Innovation Pharmaceutical Stock Forecast and Price Target

CSPC Innovation Pharmaceutical's stock price reaches the average target of 38.46 by 2025 as expected recently by notable experts, there would be a potential upside of approximately 12.23% from the last closing price in May, 2024. This possible increase is based on a high estimate of 43.50 and a low estimate of 38.33. If you are interested in 300765 stock, it is important to also consider its competitors.

38.46

12.23% Upside

Buy
Buy

CSPC Innovation Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, CSPC Innovation Pharmaceutical's Price has decreased from 18.59 to 0.00 – a 100.00% drop. For next year, analysts predict Fair Value of 21.40, which would mean an increase of 100.00%. Over the next seven years, experts predict that CSPC Innovation Pharmaceutical's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
21.40
2025 Fair Value Forecast
26.47
2026 Fair Value Forecast
44.49
2027 Fair Value Forecast
58.85
2028 Fair Value Forecast
42.36
2029 Fair Value Forecast
38.69
2030 Fair Value Forecast
41.79
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600519 Stock Forecast Kweichow Moutai Buy 10
¥1.71k Buy/Sell ¥2.22k 28.65%
600036 Stock Forecast China Merchants Bank Buy 9
¥34.31 Buy/Sell ¥42.45 13.67%
386 Stock Forecast China Petroleum & Chemical Outperform 3
HK$4.72 Buy/Sell HK$5.04 3.81%
600276 Stock Forecast Jiangsu Hengrui Medicine Buy 15
¥46.16 Buy/Sell ¥56.49 16.98%
600309 Stock Forecast Wanhua Chemical Group Buy 16
¥89.10 Buy/Sell ¥106.85 21.21%

CSPC Innovation Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030

In the last two years, CSPC Innovation Pharmaceutical's Revenue has grown by 89.90%, rising from 1.32B to 2.50B. For the following year, the 0 analysts predict that CSPC Innovation Pharmaceutical's Revenue will drop by 31.17%, reaching 1.72B. In 2030, the professionals' prediction is that 300765's Revenue will decrease by 28.21%, reaching 1.80B.

2024 Rev Forecast
1.72B
2025 Rev Forecast
1.69B
2026 Rev Forecast
1.72B
2027 Rev Forecast
1.98B
2028 Rev Forecast
1.89B
2029 Rev Forecast
1.83B
2030 Rev Forecast
1.80B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600690 Stock Forecast Haier Smart Home Buy 17
¥30.26 Buy/Sell ¥30.08 8.06%
600030 Stock Forecast CITIC Securities Company Outperform 9
¥19.01 Buy/Sell ¥26.49 30.98%
600000 Stock Forecast Shanghai Pudong Development Ba... Hold 13
¥7.70 Buy/Sell ¥7.28 3.90%

CSPC Innovation Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, CSPC Innovation Pharmaceutical's Dividend per Share has grown by 300.00%, rising from 0.08 to 0.32. In the following year, the 1 analysts surveyed believe that CSPC Innovation Pharmaceutical's Dividend per Share will decrease by 53.13%, reaching 0.15. According to professionals, by 2030, CSPC Innovation Pharmaceutical's Dividend per Share will have decreased by 29.67%, falling down to 0.23.

2024 DPS Forecast
0.15
2025 DPS Forecast
0.15
2026 DPS Forecast
0.22
2027 DPS Forecast
0.31
2028 DPS Forecast
0.25
2029 DPS Forecast
0.22
2030 DPS Forecast
0.23
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600406 Stock Forecast NARI Technology Buy 18
¥23.54 Buy/Sell ¥28.22 19.80%
T14 Stock Forecast Tianjin Pharmaceutical Da Ren ... Outperform 18
$34.99 Buy/Sell $1.70 30.89%
600016 Stock Forecast China Minsheng Banking Corp. Hold 11
¥3.95 Buy/Sell ¥3.56 -5.32%

CSPC Innovation Pharmaceutical Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
0.55B
2025 FCF Forecast
1.31B
2026 FCF Forecast
2.42B
2027 FCF Forecast
2.10B
2028 FCF Forecast
1.71B
2029 FCF Forecast
2.08B
2030 FCF Forecast
2.36B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600104 Stock Forecast SAIC Motor Corporation Outperform 17
¥14.73 Buy/Sell ¥14.70 -0.88%
600019 Stock Forecast Baoshan Iron & Steel Buy 18
¥6.95 Buy/Sell ¥7.69 13.09%
600050 Stock Forecast China United Network Communica... Outperform 16
¥4.69 Buy/Sell ¥4.97 -1.92%

CSPC Innovation Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030

CSPC Innovation Pharmaceutical's EBITDA has grown In the last two years, rising from 380.52M to 873.47M – a growth of 129.55%. In the next year, analysts believe that EBITDA will reach 987.33M – an increase of 13.04%. For the next seven years, experts predict that CSPC Innovation Pharmaceutical's EBITDA will grow at a rate of 195.44%.

2024 EBITDA Forecast
0.99B
2025 EBITDA Forecast
1.37B
2026 EBITDA Forecast
3.01B
2027 EBITDA Forecast
3.72B
2028 EBITDA Forecast
2.46B
2029 EBITDA Forecast
2.28B
2030 EBITDA Forecast
2.58B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
1171 Stock Forecast Yankuang Energy Group Company Outperform 16
HK$17.04 Buy/Sell HK$13.31 -13.62%
600436 Stock Forecast Zhangzhou Pientzehuang Pharmac... Outperform 18
¥237.24 Buy/Sell ¥302.86 19.10%
600031 Stock Forecast Sany Heavy Industry Co.,Ltd Outperform 18
¥16.31 Buy/Sell ¥18.16 -6.50%

CSPC Innovation Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030

CSPC Innovation Pharmaceutical's EBIT has seen impressive growth In the last two years, rising from 327.11M to 774.26M – a growth of 136.70%. In the next year, analysts believe that EBIT will reach 1.01B – an increase of 30.00%. For the next seven years, the forecast is for EBIT to grow by 224.33%.

2024 EBIT Forecast
1.01B
2025 EBIT Forecast
1.34B
2026 EBIT Forecast
2.90B
2027 EBIT Forecast
3.61B
2028 EBIT Forecast
2.43B
2029 EBIT Forecast
2.23B
2030 EBIT Forecast
2.51B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600018 Stock Forecast Shanghai International Port (G... Hold 18
¥5.61 Buy/Sell ¥5.18 -15.51%
600660 Stock Forecast Fuyao Glass Industry Group Buy 18
¥49.83 Buy/Sell ¥48.30 13.22%
902 Stock Forecast Huaneng Power International Outperform 8
HK$4.99 Buy/Sell HK$4.42 5.81%

CSPC Innovation Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, CSPC Innovation Pharmaceutical's EPS has decreased from 0.66 to 0.00 – a 100.00% drop. For next year, analysts predict EPS of 0.76, which would mean an increase of 100.00%. Over the next seven years, experts predict that CSPC Innovation Pharmaceutical's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
0.76
2025 EPS Forecast
0.94
2026 EPS Forecast
1.58
2027 EPS Forecast
2.09
2028 EPS Forecast
1.50
2029 EPS Forecast
1.37
2030 EPS Forecast
1.48
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600547 Stock Forecast Shandong Gold Mining Buy 10
¥28.87 Buy/Sell ¥26.15 13.34%
914 Stock Forecast Anhui Conch Cement Company Outperform 18
HK$18.26 Buy/Sell HK$24.13 10.08%
600015 Stock Forecast Hua Xia Bank Underperform 11
¥6.71 Buy/Sell ¥4.81 -26.97%